Cita APA

Nilubol, N., Boufraqech, M., Zhang, L., Gaskins, K., Shen, M., Zhang, Y., . . . Kebebew, E. (2018). Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. Oncotarget.

Citación estilo Chicago

Nilubol, Naris, Myriem Boufraqech, Lisa Zhang, Kelli Gaskins, Min Shen, Ya-Qin Zhang, Sudheer K. Gara, Christopher P. Austin, y Electron Kebebew. "Synergistic Combination of Flavopiridol and Carfilzomib Targets Commonly Dysregulated Pathways in Adrenocortical Carcinoma and Has Biomarkers of Response." Oncotarget 2018.

Cita MLA

Nilubol, Naris, et al. "Synergistic Combination of Flavopiridol and Carfilzomib Targets Commonly Dysregulated Pathways in Adrenocortical Carcinoma and Has Biomarkers of Response." Oncotarget 2018.